论文信息 - Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib - 字舞流文

Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib

S. Kim | B. Craiglow

[1] A. Gottlieb,et al. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial , 2020, The Lancet.

[2] Vishal Gupta,et al. Follicular unit extraction of leukotrichia and replacement with follicular units from scalp in combination with epidermal cell suspension in a case of vitiligo , 2020, Dermatologic therapy.

[3] B. Craiglow,et al. Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child , 2020, Pediatric dermatology.

[4] B. King,et al. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure , 2017, Journal of the American Academy of Dermatology.

[5] Ji-Hye Park,et al. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment , 2011, International journal of dermatology.

[6] Hj Song,et al. Preservation of melanoblasts of white hair follicles of segmental vitiligo lesions: A preliminary study , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7] T. Anbar,et al. The hair follicle melanocytes in vitiligo in relation to disease duration , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.